menu
    • menu

    Company profile for Eris Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Eris Pharmaceuticals (Australia) Pty Ltd is a dynamic, GMP certified pharmaceutical company focused on the development and marketing of health care products. With its headquarters located in Melbourne, Australia, Eris Pharmaceuticals was founded in 2009, and by creating core business subsidiaries in selected countries such as the regional offices in Athens, it has achieved a quick expansion and presence in the MENA region, CIS...
    Eris Pharmaceuticals (Australia) Pty Ltd is a dynamic, GMP certified pharmaceutical company focused on the development and marketing of health care products. With its headquarters located in Melbourne, Australia, Eris Pharmaceuticals was founded in 2009, and by creating core business subsidiaries in selected countries such as the regional offices in Athens, it has achieved a quick expansion and presence in the MENA region, CIS countries and Balkans. Nowadays, Eris Pharmaceuticals is present in more than 25 markets, and with a rapidly increasing product portfolio, is set to further expand and grow its presence in the respective markets.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Eris PharmaceuticalsAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Shop 5/148-152 Spit Road, Mosman, Sydney 2088, New South Wales
    Telephone
    Telephone
    +61 2 9960 2760
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.eris-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eris Lifesciences Q2FY25 Profit Falls 25.8%, Revenue Up 46.6%
    Eris Lifesciences Q2FY25 Profit Falls 25.8%, Revenue Up 46.6%

    25 Oct 2024

    // BUSINESS STD

    https://www.business-standard.com/companies/results/eris-lifesciences-q2fy25-results-profit-skids-25-8-revenue-up-46-6-124102501368_1.html

    BUSINESS STD
    25 Oct 2024
    Share Share
    Intimation under Regulation 30 of Update on divestment of Eris Ph
    Intimation under Regulation 30 of Update on divestment of Eris Ph

    02 Feb 2024

    // PRESS RELEASE

    https://www.strides.com/pdf/pressrelease/2024/StridesSEIntimationEris_02Feb2024.pdf

    PRESS RELEASE
    02 Feb 2024
    Share Share
    Eris enters dermatology therapy, acquires Oaknet Healthcare for Rs 6,500 million
    Eris enters dermatology therapy, acquires Oaknet Healthcare for Rs 6,500 million

    05 May 2022

    // EXPRESS PHARMA

    https://www.expresspharma.in/eris-enters-dermatology-therapy-acquires-oaknet-healthcare-for-rs-6500-million/

    EXPRESS PHARMA
    05 May 2022
    Share Share
    Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn
    Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn

    04 Dec 2019

    // BUSINESS STANDARD

    https://www.business-standard.com/article/companies/eris-lifesciences-acquires-trademark-zomelis-from-novartis-ag-for-13-mn-119120301413_1.html

    BUSINESS STANDARD
    04 Dec 2019
    Share Share
    Eris Lifesciences, PlexusMD join hands to offer AI powered learning platform
    Eris Lifesciences, PlexusMD join hands to offer AI powered learning platform

    01 Jul 2019

    // PHARMABIZ

    http://www.pharmabiz.com/ArticleDetails.aspx?aid=116678&sid=2

    PHARMABIZ
    01 Jul 2019
    Share Share
    Eris Lifesciences trades higher for fifth straight trading day
    Eris Lifesciences trades higher for fifth straight trading day

    05 Mar 2018

    // BUSINESS-STANDARD

    http://www.business-standard.com/article/markets/eris-lifesciences-trades-higher-for-fifth-straight-trading-days-118030600149_1.html

    BUSINESS-STANDARD
    05 Mar 2018
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search